GTC Biotherapeutics (fka GTCB)

[MTB]

A small, struggling MA biotech gets unsolicited buyout offer for approx 300% above current trading at time . . .

In this case, it is NTMD, but their consideration of an unsolicited offer is increasingly where I see GTCB going in the next 6-8 months.

Where for months I've feared the unsolicited buyout off as a devastating short-circuiting of GTCB's tremendous long-term potential, given Cox's et al's inadequacies, I'm thinking it might be the best we can hope for.

Whatever the results of the Dec 10th vote (I voted no x 3), it seems unlikely that GTCB will simply vanish into bankrupcy. A buy-out, a low prob event. An ongoing string of dilutions the greatest (and most likely) evil outcome.

Best,
MTB